United KingdomHealthcare and life sciences2022 – ongoingNHS Lothian
Infix scheduling across surgical specialties
NHS Lothian's Infix evaluation found 25% higher ophthalmology throughput per hour, with mixed results elsewhere
Problem
NHS Lothian needed to increase surgical capacity while addressing waiting-list backlogs. More efficient theatre schedules offered a way to use existing resources.
Approach
NHS Lothian contracted for Infix in 2022. An independent evaluation examined theatre efficiency across 4 specialties over 24 weeks. The scheduling software used machine learning.
Results
Takeaway
Results differed by specialty. Higher ENT utilisation did not increase patient throughput, and maxillofacial and plastic surgery showed no significant efficiency changes.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and MLOptimization
- Adoption
- Vendor solution
- Evidence
- Independent study
Sources
Source summaries
SHTG reported its independent evaluation of Infix at NHS Lothian. Ophthalmology throughput per hour rose 25%, while results in the other specialties were mixed.
The briefing identified Infix as machine-learning scheduling software bought by NHS Lothian. It cited the November 2022 contract announcement and SHTG's subsequent evaluation.
Full details are in the original sources.